T-lamirenz Tablet (Lamivudine + Tenofovir disoproxil fumarate + Efavirenz)
T-lamirenz Tablet (Lamivudine + Tenofovir disoproxil fumarate + Efavirenz)

T-lamirenz Tablet (Lamivudine + Tenofovir disoproxil fumarate + Efavirenz)

prescriptionImage Prescription Required

Manufactured By

Arechar Healthcare

Pack Of

30

Salt Composition

Lamivudine + Tenofovir disoproxil fumarate + Efavirenz

Storage

Keep in cold place

Safe and Secure


Your health and safety are our top priority. All our medicines are sourced from trusted suppliers, thoroughly tested, and approved for use. We follow strict quality control standards to ensure every product is safe, effective, and reliable. You can enquire knowing your wellness is in good hands.

Overview

T-lamirenz Tablet is an antiviral medication that is used to treat Human Immunodeficiency virus (HIV) Infection.This antiviral mainly treats the chronic infection in the body. It contain the fixed dose combination of Efavirenz, Lamivudine and Tenofir Disoproxil Fumarate salt that attacks the viral replication machinery in the host's body.

All salts stops viral replication mainly by being converted inside infected cells into an active form that directly inhibits the viral RNA polymerase enzyme, preventing the virus from copying its genetic material correctly.

It also increases mutations in viral RNA, causing the production of defective viruses, and modulates the immune response to enhance antiviral activity. As a result, it reduces viral load in the body, reduces viral inflammation, controls virus progression as well as ultimately eradicating virus traces in the body.

Quick Product Facts

FieldPublication wording
Brandt lamirenz
Generic / Active IngredientLamivudine + Tenofovir disoproxil fumarate + Efavirenz
Strength300
Dosage FormTablet
Manufacturer / MarketerArechar Healthcare
Pack Size30
Prescription RequiredYes
Therapeutic CategoriesHIV Medicines
UsesHIV

Uses and Indications

HIV

Side Effects of T-lamirenz Tablet

Lamivudine + Tenofovir disoproxil fumarate + Efavirenz tablet (T-lamirenz) cause multiple side effects like any other chemical based medication. Side effects may range from mild to extreme. Any persistent, worsening, or unusual symptoms should be immediately reported to the doctor.
Common Side Effects of T-lamirenz Tablet
● Dizziness
● Headache
● Nausea
● Vomiting
● Fatigue
● Weakness
● Cough
● Skin Rashes
● Congestion
● Muscle or Joint Pain
● Low Phosphate in Blood

Common or Clinically Frequent Side Effects

  • Less Common Side Effects of T-lamirenz Tablet
  • ● Severe Allergic Reactions
  • ● Extreme Mood Changes such as Depression, Anxiety, Suicidal thoughts etc.
  • ● Liver Problems
  • ● Liver Damage
  • ● Kidney Problems
  • ● Lactic Acidosis
  • ● Blood Problems
  • ● Low Bone Density

T-lamirenz Tablet Dosage and How To Take It

T-lamirenz Tablet (Lamivudine + Tenofovir disoproxil fumarate + Efavirenz) is taken orally. Tablet is swallowed as it is with the help of water. It can be taken after or before food consumption.

Although taking it on an empty stomach or at bedtime is often recommended to reduce side effects. Avoid crushing, chewing, breaking or biting of tablet to maintain its efficacy. In general, T-lamirenz Tablet dosage is just one tablet at the same time every day.For more personalized assistance and exact dosage, talk to your doctor about the same.

Safety Advice for T-lamirenz Tablet

  • 1. It is generally advice to avoid alcohol consumption while taking T-lamirenz Tablet due to its negative impact on body as well as medication reaction. For more details, Consult your Doctor.
  • 2. T-lamirenz is not prescribed at the time of pregnancy. It causes harm to growing fetus. Consult your doctor in case of accidental pregnancy or any further risks.
  • 3. In general there is no data related to Lamivudine + Tenofovir disoproxil fumarate + Efavirenz (T-lamirenz) and its effect on breast feeding. But it is generally not advisable during the medication course. Consult your Doctor for more information.
  • 4. It is advisable not to drive, as you may feel dizzy and can come across blurred vision after taking T-lamirenz Tablet.
  • 5. Share your medical history details related to kidney cancer or any other disease with your doctor before taking T-lamirenz.
  • 6. Notify your doctor about any liver disease or infection before starting T-lamirenz Tablet course.As it can cause serious liver damage.

FAQs About T-lamirenz Tablet

What is the purpose of T-lamirenz Tablet?

downArrowImg

The purpose of T-lamirenz Tablet is to treat Human Immunodeficiency Virus (HIV) Infection in the body.

How does T-lamirenz Tablet work?

downArrowImg

T-lamirenz Tablet is a combination of three antiviral chemical based salt. Salts inhibit the necessary enzymes of HIV that are responsible for viral replication in the host's body. As a result, viral load reduced.

What is the composition of T-lamirenz Tablet?

downArrowImg

The composition of T-lamirenz Tablet is Efavirenz, Lamivudine and Tenofir Disoproxil Fumarate.

How to store T-lamirenz Tablet?

downArrowImg

Store T-lamirenz Tablet at room temperature, preferably below 30degree celcius. Kept it in an original container, tightly closed, protect it from direct moisture and light. Keep it out of reach of children and pets.

What are the common side effects of T-lamirenz Tablet?

downArrowImg

The common side effects of Lamivudine + Tenofovir disoproxil fumarate + Efavirenz Tablet (T-lamirenz) are Diarrhea, Insomnia, Nausea, Weakness, Rashes, Depression, Dizziness, Cough, Fever etc.

References

● Elliott, W., & Chan, J. (2018). Efavirenz, lamivudine, and tenofovir disoproxil fumarate tablets (Symfi). Internal Medicine Alert, 40(9).
● Rakhmanina, N. Y., & Van den Anker, J. N. (2010). Efavirenz in the therapy of HIV infection. Expert opinion on drug metabolism & toxicology, 6(1), 95-103.
● Venter, W. D., Sokhela, S., Simmons, B., Moorhouse, M., Fairlie, L., Mashabane, N., ... & Hill, A. (2020). Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial. The lancet HIV, 7(10), e666-e676.
● Dando, T. M., & Wagstaff, A. J. (2004). Emtricitabine/tenofovir disoproxil fumarate. Drugs, 64(18), 2075-2082.

Marketer Details

Arechar Healthcare

Author Details

logoImg

Written By:

Nonish Sharma

I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More


reviewerImg

Reviewed By:

Vaibhav Shakya

Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More

Last Updated: 19 Oct 2026 | 02:31 pm (IST)

Want to know More

Check our Editor Policy

Disclaimer

Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.

Chat on WhatsApp